Endo International plc (NASDAQ: ENDP) shares were trading lower Thursday after the company announced it will present data on the use of a standing MRI versus a prone MRI for the evaluation of cellulite at the Annual Meeting of the American Society for Dermatologic Surgery in Chicago.
The company said it will display two posters from Thursday through Sunday.
The first poster is a case study comparison of the use of a standing MRI versus a prone MRI for the evaluation of cellulite.
The second poster is an encore presentation of the Phase 3 data of collagenase clostridium histolyticum for the investigational treatment of cellulite.
Endo shares were down 7.16% at $4.41 at the time of publication.
See more from Benzinga
- As Draghi Exits ECB, More Signs Of Struggle In German Economy
- Airline Earnings: Southwest, American Report Strong Q3 Despite Continued 737 MAX Grounding
- Twitter Nosedives On Mixed Q3 Print; Monetizable Daily Active Users Rise 17% Year-Over-Year
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.